EyePoint Pharmaceuticals Inc

EYPT NASDAQ Santé & Biotech États-Unis US30233G2093
12.50 $
0.48 %

EyePoint Pharmaceuticals développe et commercialise des dispositifs d'implantation médicale et des médicaments pour traiter les maladies oculaires.

Performance & Momentum

6 Months 21.83 %
1 Year 41.08 %
3 Years 98.10 %
5 Years 31.58 %

Similar stocks to EyePoint Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on EyePoint Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases